Dnmt3a-Mutant Hematopoietic Stem cells are resistant to inflammatory stress
Ontology highlight
ABSTRACT: Dnmt3a-mutant mouse HSCs, but not control HSCs are able to maintain clonality during type II inteferson signaling. To investigate the molecular mechanism of this observation, we investigated IFNg-incuded changes in DNA methylome of mouse HSCs in a mouse model. In the model, we transplanted 10% CD45.2 donor BM cells, 10% CD45.1/2-GFP competitors and 80% CD45.1 BM cells into CD45.1 recipients. In the treatment group, we transplated the CD45.1 BM cells with the genotype of IFNgrKO; rtTA-M2; Tet-O-IFNg to induce a chronic IFNg exposure. A physiological relevant level of IFNg was induced by 1250ppm doxycycline chow every other week during 5-24 weeks post-transplant. In the control group, we transplanted CD45.1 cells with the genotype of IFNgrKO; rtTA-M2. All the mice in the control group were also on the same schedule of doxycycline chow. Recipients were sacrificed 26-weeks post-transplant and 3x10^5 donor derived BM cells from each group were sorted for gDNA extraction. Consistent with literature, our results showed a gradient loss of DNA methylation from Dnmt3a-HET to Dnmt3a-KO compared to Vav-cre controls. Chronic IFNg exposure, however, did not change the global DNA methylation levels. All the IFNg-induced changes were locus-specific. We conclud that IFNg-induced changes in DNA methylome cannot explain the protection of Dnmt3a-mutant HSCs against type II inteferon signaling.
ORGANISM(S): Mus musculus
PROVIDER: GSE168807 | GEO | 2022/02/22
REPOSITORIES: GEO
ACCESS DATA